What are dermal fillers? Dermal fillers help to diminish
facial lines and restore volume and fullness in the face. As we age, our faces naturally lose subcutaneous fat. The facial
skin also stretches a bit, adding to this loss of facial volume. Dermal fillers
can be used to add more volume to the lips, soften facial creases and wrinkles
and enhance facial contours. Common places to use dermal fillers are the lips,
nasolabial folds, marionette lines and cheeks.
There are several different
types of dermal fillers. Dermal fillers differ in chemical make-up, longevity,
and have varying degrees of softness. Softer fillers are used in the lips, for
example, while sturdier fillers might be desired to enhance cheekbones. For
many people, the use of “off-the-shelf” fillers can be a simple office-based
procedure that can nicely enhance your appearance. These dermal fillers are
very predictable, and have relatively minimal risks and side effects. One of
the most common fillers is hyaluronic acid because of its compatibility with
the human body. Hyaluronic acid is a natural substance found in your body. High
concentrations are found in soft connective tissues and in the fluid
surrounding your eyes. It's also in some cartilage and joint fluids, as well as
skin tissue. It is extracted and reformulated and now has become one of the
most popular kinds of injectable fillers. Common brand names include Juvéderm and
Restylane. When this gel is injected, it acts like an inflated cushion to
support facial structures and tissues that may have lost volume or elasticity
due to normal aging. It also brings water to the surface of skin to keep it
looking fresh and supple.
Of note, Botox is not a
dermal filler. Botox acts by diminishing active lines such as glabellar frown
lines, forehead lines and crows feet lines. As of this date, there has not been
side effects from Botox related to the
COVID-19 vaccine.
In December 2020, the
FDA approved the Moderna COVID-19 vaccine. During Moderna’s initial studies, 3 patients out of 15,184 receiving the
MODERNA SARS-CoV-2 mRNA vaccine had developed facial swelling after
vaccination. The three patients were in Moderna’s Phase Three trial and
developed facial (2 patients) and lip (1 patient) swelling. Two of the
patients had a history of dermal filler placement 6 months and 2 weeks prior to
vaccination. One patient had lip dermal filler 2 days after receiving the
vaccine. All events (swelling and inflammation) occurred within two days of
receiving the vaccine dose. All patients reported complete resolution of these
effects by treatment with oral steroids and antihistamines which quickly
resolved the reactions.
Therefore, the FDA is reporting that people with cosmetic facial fillers could
experience localized facial swelling and inflammation after receiving the
Moderna vaccine for COVID-19. The reactions have been mild, and physicians say
this information should not stop people from getting the vaccine when able.
I
feel that dermal fillers should be
administered by board-certified physicians who are experts in both the
injection of dermal fillers and management of complications arising from them.